Skip to main content

Advertisement

Table 4 Medications used for continuous prophylactic treatment by patients with HAE-nlC1-INH

From: Abstracts of 11th C1-inhibitor Deficiency & Angioedema Workshop

  TOTAL (66/143 = 46.1%) HAE – F12 (53/116 = 45.7%) HAE – UNKNOWN (12/25 = 48%) Angiopoetin 1 (1/2 = 50%)
n = 66 % n = 53 % n = 12 % n = 1 %
Tranexamic acid 52 78.8 43 81.1 8 66.7 1 100
Danazol 20 30.3 12 22.6 7 58.3 1 100
Oxandrolone 14 21.2 8 15.1 5 41.7 1 100
Epsilon aminocaproic acid 4 6.1 0   3 25 1 100